StoneX Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
+9,063
| New | +$221K | 0.01% | 748 |
|
|
2024
Q4 | – | Sell |
-8,045
| Closed | -$206K | – | 865 |
|
|
2024
Q3 | $206K | Sell |
8,045
-888
| -10% | -$22.7K | 0.09% | 311 |
|
|
2024
Q2 | $210K | Buy |
8,933
+652
| +8% | +$15.3K | 0.1% | 294 |
|
|
2024
Q1 | $238K | Buy |
8,281
+238
| +3% | +$6.85K | 0.12% | 241 |
|
|
2023
Q4 | $264K | Sell |
8,043
-73
| -0.9% | -$2.4K | 0.14% | 216 |
|
|
2023
Q3 | $226K | Buy |
8,116
+54
| +0.7% | +$1.5K | 0.13% | 254 |
|
|
2023
Q2 | $275K | Buy |
8,062
+982
| +14% | +$33.5K | 0.15% | 201 |
|
|
2023
Q1 | $213K | Buy |
+7,080
| New | +$213K | 0.13% | 275 |
|
|
2022
Q4 | – | Sell |
-12,054
| Closed | -$396K | – | 592 |
|
|
2022
Q3 | $396K | Sell |
12,054
-703
| -6% | -$23.1K | 0.07% | 182 |
|
|
2022
Q2 | $402K | Buy |
12,757
+1,641
| +15% | +$51.7K | 0.07% | 201 |
|
|
2022
Q1 | $511K | Buy |
11,116
+1,303
| +13% | +$59.8K | 0.05% | 309 |
|
|
2021
Q4 | $601K | Buy |
9,813
+1,005
| +11% | +$61.5K | 0.07% | 260 |
|
|
2021
Q3 | $658K | Buy |
8,808
+259
| +3% | +$19.3K | 0.09% | 211 |
|
|
2021
Q2 | $791K | Buy |
8,549
+1,142
| +15% | +$106K | 0.12% | 184 |
|
|
2021
Q1 | $657K | Sell |
7,407
-4,018
| -35% | -$356K | 0.12% | 175 |
|
|
2020
Q4 | $1.07M | Buy |
11,425
+2,722
| +31% | +$254K | 0.23% | 85 |
|
|
2020
Q3 | $554K | Buy |
8,703
+3,786
| +77% | +$241K | 0.18% | 135 |
|
|
2020
Q2 | $256K | Buy |
+4,917
| New | +$256K | 0.1% | 232 |
|